Tango Therapeutics, Inc. (NASDAQ: TNGX - Get Free Report)'s share price shot up 6.1% on Friday. The

Mizuho analyst Joseph Catanzaro maintains Tango Therapeutics (NASDAQ:TNGX) with a Outperform and

Wall Street analysts initiated coverage on various top stocks, including VCYT, UMAC, FISN, LTRX, and

JP Morgan analyst Brian Cheng initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Overw

Tango Therapeutics' strong 2026 rally reflects promising clinical progress, but its premium valuatio

TNGX is advancing precision oncology with MTAP-targeted therapies and 2026 data readouts that could

Tango Therapeutics enters a pivotal phase as vopimetostat drives its investment case, with 2026 clin

Canaccord Genuity analyst John Newman maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and r

Jefferies analyst Maury Raycroft upgrades Tango Therapeutics (NASDAQ:TNGX) from Hold to Buy and r

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage

BOSTON, June 09, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (“Tango”) (Nasdaq: TNGX), a clini

Tango Therapeutics rises 53% after early pancreatic cancer study data show strong response rates for

AAPL, SUNE, TNGX, APLD, CBRS were among the stocks seen trending on Monday, June 8, 2026.

Tango Therapeutics, Inc. (TNGX) Discusses Promising Clinical Results for Vopimetostat and Pan-RAS In

BOSTON, June 08, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (“Tango”) (Nasdaq: TNGX), a clini

Shares of Tango Therapeutics (TNGX) surged more than 51% on Monday after the clinical-stage biotechn

Tango Therapeutics stock soars after the biotech company announces initial data from its ongoing stu

US stocks rose with Nasdaq up 400 points. Dow up 0.32%, Nasdaq up 1.55%, S&P 500 up 0.94%. Tech

U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Monday.

U.S. stocks higher, Nasdaq Composite up 1%. Tango Therapeutics (TNGX) shares up 34.1% on positive tr

Tango Therapeutics said on Monday an experimental drug combination showed strong early results in a

Initial data from ongoing Phase 1/2 trial in patients with second and third line PDAC treated with v

BOSTON, June 05, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced t

This biotechnology firm advances targeted cancer therapies, leveraging genetic insights and strategi

Top analysts changed outlook on top names. See all rating changes on analyst ratings page. Check out

U.S. stock futures lower, Nasdaq down 1%. DeFi Technologies (DEFT) shares fell 5.3% after Q1 results

Figma Inc (NYSE: FIG) shares rose 10.6% in pre-market trading after beating Q1 revenue and earnings

First clinical data from PRMT5/RAS(ON) combination trial to be pre sented in 2026 Cash position of $

BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced th

Massachusetts Financial Services Co. MA acquired a new stake in Tango Therapeutics, Inc. (NASDAQ: TN

Tango Therapeutics, Inc. (NASDAQ: TNGX - Get Free Report) insider Adam Crystal sold 38,460 shares of

  During Wednesday's session, 212 companies made new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.

  During Monday's trading, 1214 companies set new 52-week lows.

  On Thursday, 112 stocks made new 52-week lows.